Opportunities
Search

Buyer: Gemeente Helmond | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Nederlandse Organisatie voor Wetenschappelijk Onderzoek | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Freistaat Bayern, vertreten durch das Bayerische Landesamt für Umwelt | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Gemeente Meierijstad | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-02

Buyer: gemeente Nissewaard | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: SITREVA | Notice type: cn-standard | Contract: services | Deadline: 2026-09-02

Buyer: Transports publics de la région lausannoise sa | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-09-02

Buyer: Freistaat Bayern, vertreten durch das Bayerische Landesamt für Umwelt | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Buyer: Freistaat Bayern, vertreten durch das Bayerische Landesamt für Umwelt | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-09-02

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Idea Development Award (IDA) supports conceptually innovative, high-risk/high-reward research that could lead to critical discoveries or major advancements that will accelerate progress toward eradicating deaths and suffering from lung cancer. This mechanism promotes new ideas that are in the early stages of development and have the potential to yield impactful data and new avenues of investigation. Research must address at least one of the FY26 LCRP areas of emphasis.Distinctive Features: This FY26 LCRP IDA mechanism has a New Investigator category that is designed to allow applicants early in their faculty appointments to compete for funding separately from established investigators. Preliminary data to support the feasibility of the research hypotheses and research approaches are required; however, these data do not necessarily need to be derived from studies of lung cancer.

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 – Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 – Pilot clinical trials of novel interventions.

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category.Distinctive Features:• This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver.• This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.

Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Data Science Award (DSA) supports research that develops or uses quantitative and analytical approaches, processes and/or systems to obtain knowledge and insight from large and/or complex sets of prostate cancer data in one or more of the following research areas: Analysis of clinically annotated datasets; analysis of -omics data; artificial intelligence and machine learning; bioinformatics; computational biology; digital pathology; epidemiology; and medical imaging. All applications must address one of the FY26 PCRP Overarching Challenges. Distinctive Features: This funding mechanism allows for multiple Principal Investigators (PIs). Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.

Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (EIRA) supports prostate cancer research conducted by investigators in the early stages of their careers with guidance from an experienced mentor. All applications must address one of the FY26 PCRP Overarching Challenges. Distinctive Features: ·        Early-Career Investigator: Serves as the principal investigator. Includes investigators possessing a doctoral degree or equivalent with fewer than three years of postdoctoral research experience at the application submission deadline, excluding clinical residency or clinical fellowship training. ·        Mentorship: Applications must include at least one mentor who demonstrates experience in prostate cancer research and successful mentorship. ·        Researcher Development Plan: Applications must include a researcher development plan articulating an individualized strategy for acquiring necessary skills, competence, and expertise to complete the project and foster the Principal Investigator’s (PI’s) career development

Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Physician Research Award (PRA) Supports a mentored research experience to prepare physicians with clinical duties for careers in prostate cancer research. All applications must address one of the FY26 PCRP Overarching Challenges. Distinctive Features: ·        Early-Career Clinician Investigator: Serves as the Principal Investigator (PI). Includes investigators with clinical duties in the last year of an accredited medical residency or medical fellowship program, or within five years of initiating a faculty appointment. ·        Mentorship: Applications must include at least one mentor who demonstrates experience in prostate cancer research and successful mentorship. ·        Researcher Development Plan: Applications must include a research development plan articulating an individualized strategy for acquiring necessary skills, competence and expertise to complete the projects and foster the PI’s career development. https://cdmrp.health.mil/pubs/press/2026/pcrppreann

Summary: The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) supports new ideas that represent innovative approaches to prostate cancer research and have the potential to make an important contribution to the PCRP mission. All applications must address one of the FY26 PCRP Overarching Challenges. Distinctive Features: ·        New Investigator Category: In addition to established investigators, the FY26 PCRP Idea Development Award encourages research ideas from investigators in the early stages of their careers (i.e., within 10 years after completion of their terminal degree). Qualified new investigators must identify a collaborator(s) experienced in prostate cancer research.   https://cdmrp.health.mil/pubs/press/2026/pcrppreann

Expected Impact:In the long-term, the funding is expected to:have increased operational capacity of law enforcement authorities to fight organised crime, including an improved capability to trace and untangle complex money laundering schemes.have improved cross-border cooperation and sharing of challenges and best practices in fighting against organised crime.have improved detection, identification and referral of victims of crime in the context of cross-border operational actions, as well as improved protection of victims in criminal proceedings, in cooperation with civil society organisations. Expected Outcome:Projects should aim to achieve one or more of the following outcomes:increase understanding of the nature and modus operandi of criminal networks and key actors and enablers.enhance coordination of law enforcement authorities in cross-border operations and support multi-stakehold...

Expected Impact:In the long-term, the funding is expected to:have increased operational capacity of law enforcement and other security-oriented authorities to fight organised crime and drug production and trafficking, including an improved capability to trace and untangle complex money laundering schemes as well as illicit flows of goods.enhance risk assessments and risk awareness and resilience measures in view of anticipating, preventing and tackling organised crime and drug related crimes.have improved cross-border cooperation including with key third countries and information exchange (including where possible and applicable with the private sector) and sharing of challenges and good practices in fighting against organised crime.have improved detection, identification and referral of victims of crime in the context of cross-border operational actions, as well as improved protection o...

Expected Outcome:The topic encompasses actions within the scope of the co-programmed European Partnership on Globally Competitive Space Systems (‘Space Partnership’) in the areas of satellite communication (SatCom), Earth Observation (EO) and New Commercial Space Transportation Solutions and is part of cohesive activities in the domain of digital developments under the grand heading of “digitalisation for commercial space solutions”.Digitalisation is a major enabler for enhancing the value of an End-to-End EO and SatCom system. Under the area of Using Space on Earth related to SatCom and EO, below this topic focus on the fast increment of the Low to Mid TRL level building blocks for key technologies[1] required to strengthen competitiveness in these domains.Projects are expected to contribute to one or several of the following outcomes:New commercial services and applications enabled by...

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space Equipment and related technologies across their entire supply chain;Providing unrestricted access to critical space Equipment and related technologies relevant for EU space missions and pilots (e.g. In-Orbit Space Operations);Developing or regaining capacity to operate independently in space by developing resilient space Equipment and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions;Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the EU and compete at worldwide level. Scope:Unrestricted access to state-of-art space...

Expected Outcome:Project results are expected to contribute to all of the following outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies for accessing space;Providing an EU access to space necessary for EU space missions through state of the art and innovative solutions;Diversifying the access to space providers in the EU;Contributing to expand commercial access to space offers and services in the EU;Reinforcing Access to Space to ensure that Europe maintains and improve autonomous, reliable and cost-effective access to space. Scope:The EU needs to improve the resilience of its access to space for the implementation of EU space programme. New entrants will contribute to this endeavour.Projects are expected to support EU launch service providers to set up launch pad(s) in the EU territory enabling to perform EU launch services.Projects are expected to contribute to t...

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space EEE components across their entire supply chain, including radiation testing facilities;Providing unrestricted access to critical space EEE components and testing facilities relevant for EU space missions (Galileo, EGNOS, Copernicus, IRIS2 and EU pilot missions on In-Orbit Space Operations and Quantum Gravimetry);Developing or regaining capacity to operate independently in space by developing resilient space EEE components and testing facilities supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions;Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from ou...

Expected Outcome:The topic encompasses actions within the scope of the co-programmed European Partnership on Globally Competitive Space Systems (‘Space Partnership’) in the areas of satellite communication (SatCom), Earth Observation (EO) and New Commercial Space Transportation Solutions and is part of cohesive activities in the domain of digital developments under the grand heading of “digitalisation for commercial space solutions”.Digitalisation is a major enabler for enhancing the value of an End-to-End EO and SatCom system. Under the area of Using Space on Earth related to SatCom and EO, below this topic focusses on the Mid to High TRL level developments of key technologies[1] required to strengthen competitiveness in these domains, contributing to the preparation of EO and SatCom demonstration missions.Projects are expected to contribute to one or several of the following outcomes:F...

Expected Outcome:Project results are expected to contribute to the following expected outcomes:European space science breakthroughs fostered by data analysis and exploitation of European missions (incl. low-cost/small satellite) and instruments, in conjunction, when relevant, with international missions. This data may also originate from European in-orbit validation experiments with a focus on space science and exploration.A higher number of European scientific publications based on space data, high-level data products made available through appropriate archives, and tools and methods developed for the advanced processing of data.Increased collaboration of scientific teams both within and outside Europe across different domains, adding value to existing activities on European and international levels and enhancing and broadening research partnerships.European scientific excellence and de...

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Reinforcing EU strategic autonomy by reducing non-EU dependencies on critical space EEE components and related technologies across their entire supply chain;Providing unrestricted access to critical space EEE components and related technologies relevant for EU space missions (Galileo, EGNOS, Copernicus, IRIS2 and EU pilot missions on In-Orbit Space Operations and Quantum Gravimetry);Developing or regaining capacity to operate independently in space by developing resilient space EEE components and related technologies supply chains, relying on EU supply chains and/or trustable and reliable supply chains not affected by non-EU export restrictions;Enhancing competitiveness by developing products and capabilities reaching equivalent or superior performance level than those from outside the E...